{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:30:21Z","timestamp":1793773821395,"version":"4.6.1"},"reference-count":95,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic graft versus host disease (GVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation. Clinically, chronic GVHD is a pleiotropic, multiorgan syndrome involving tissue inflammation and fibrosis that often results in permanent organ dysfunction. Chronic GVHD is fundamentally caused by replacement of the host\u2019s immune system with donor cells, although the heterogeneity of clinical manifestations suggests that patient, donor, and transplant factors modulate the phenotype. The diagnosis of chronic GVHD and determination of treatment response largely rely on clinical examination and patient interview. The 2005 and 2014 National Institutes of Health Consensus Development Projects on Criteria for Clinical Trials in Chronic GVHD standardized the terminology around chronic GVHD classification systems to ensure that a common language and procedures are being used in clinical research. This review provides a summary of these recommendations and illustrates how they are being used in clinical research and the potential for their use in clinical care.<\/jats:p>","DOI":"10.1182\/blood-2016-07-686642","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T20:37:13Z","timestamp":1478551033000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":287,"title":["Classification systems for chronic graft-versus-host disease"],"prefix":"10.1182","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"first","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020071614175854700_B1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/asheducation-2008.1.134","article-title":"Recognizing and managing chronic graft-versus-host disease","volume":"2008","author":"Lee","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"2020071614175854700_B2","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"issue":"17","key":"2020071614175854700_B3","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2020071614175854700_B4","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2020071614175854700_B5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"Soci\u00e9","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"2020071614175854700_B6","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.2009.26.7757","article-title":"Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase","volume":"28","author":"Goldman","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"2020071614175854700_B7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation","volume":"28","author":"Martin","year":"2010","journal-title":"J Clin Oncol"},{"issue":"16","key":"2020071614175854700_B8","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"2020071614175854700_B9","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3324\/haematol.2011.046367","article-title":"Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium","volume":"96","author":"Pidala","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"2020071614175854700_B10","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-03-1010","article-title":"Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study","volume":"104","author":"Baker","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2020071614175854700_B11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.2011.38.4594","article-title":"Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation","volume":"30","author":"Khera","year":"2012","journal-title":"J Clin Oncol"},{"issue":"17","key":"2020071614175854700_B12","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"issue":"19","key":"2020071614175854700_B13","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.291.19.2335","article-title":"Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma","volume":"291","author":"Syrjala","year":"2004","journal-title":"JAMA"},{"key":"2020071614175854700_B14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2020071614175854700_B16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-9343(79)91171-9","article-title":"Chronic graft versus host disease: a syndrome of disordered immunity","volume":"66","author":"Graze","year":"1979","journal-title":"Am J Med"},{"issue":"3","key":"2020071614175854700_B17","first-page":"545","article-title":"Chronic cutaneous graft-versus-host disease in man","volume":"91","author":"Shulman","year":"1978","journal-title":"Am J Pathol"},{"issue":"2","key":"2020071614175854700_B18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"issue":"3","key":"2020071614175854700_B19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5045\/kjh.2011.46.3.153","article-title":"Treatment of chronic graft-versus-host disease: Past, present and future","volume":"46","author":"Martin","year":"2011","journal-title":"Korean J Hematol"},{"issue":"3","key":"2020071614175854700_B20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbmt.2015.10.018","article-title":"Late acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"22","author":"Arora","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"2020071614175854700_B21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"2020071614175854700_B22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","article-title":"Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial","volume":"11","author":"Friedrichs","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"2020071614175854700_B23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"issue":"9","key":"2020071614175854700_B24","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood.V100.9.3128","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study","volume":"100","author":"Mohty","year":"2002","journal-title":"Blood"},{"issue":"25","key":"2020071614175854700_B25","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1182\/blood-2011-01-332007","article-title":"Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies","volume":"117","author":"Soiffer","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2020071614175854700_B26","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"2020071614175854700_B27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"2020071614175854700_B28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","article-title":"Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial","volume":"17","author":"Walker","year":"2016","journal-title":"Lancet Oncol"},{"issue":"6","key":"2020071614175854700_B29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"2020071614175854700_B30","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2020071614175854700_B31","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood-2015-10-672071","article-title":"Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation","volume":"127","author":"Mielcarek","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2020071614175854700_B32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2020071614175854700_B33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"issue":"10","key":"2020071614175854700_B34","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bbmt.2007.06.004","article-title":"Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB)","volume":"13","author":"Arora","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.beha.2010.09.016","article-title":"Have we made progress in the management of chronic graft-vs-host disease?","volume":"23","author":"Lee","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"2020071614175854700_B36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2020071614175854700_B37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","article-title":"Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report","volume":"12","author":"Shulman","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2020071614175854700_B38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbmt.2005.11.010","article-title":"Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report","volume":"12","author":"Schultz","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2020071614175854700_B39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","article-title":"Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2020071614175854700_B41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbmt.2006.03.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report","volume":"12","author":"Martin","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B42","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/bmt.2013.225","article-title":"Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD","volume":"49","author":"Inamoto","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2020071614175854700_B43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbmt.2014.12.035","article-title":"2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series","volume":"21","author":"Pavletic","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2020071614175854700_B44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report","volume":"21","author":"Carpenter","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020071614175854700_B45","author":"Jagasia"},{"issue":"6","key":"2020071614175854700_B46","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2020071614175854700_B47","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bbmt.2015.05.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report","volume":"21","author":"Martin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2020071614175854700_B48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report","volume":"21","author":"Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2020071614175854700_B50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"issue":"2","key":"2020071614175854700_B51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bmt.2008.305","article-title":"New classification of chronic GVHD: added clarity from the consensus diagnoses","volume":"43","author":"Arora","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2020071614175854700_B52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/leu.2008.276","article-title":"Feasibility of NIH consensus criteria for chronic graft-versus-host disease","volume":"23","author":"Cho","year":"2009","journal-title":"Leukemia"},{"issue":"4","key":"2020071614175854700_B53","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/leu.2011.257","article-title":"Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study","volume":"26","author":"Kuzmina","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"2020071614175854700_B54","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"Vigorito","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2020071614175854700_B55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3324\/haematol.2011.055186","article-title":"Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study","volume":"97","author":"Pidala","year":"2012","journal-title":"Haematologica"},{"issue":"11","key":"2020071614175854700_B56","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bmt.1703278","article-title":"Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease","volume":"28","author":"Jacobsohn","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"2020071614175854700_B57","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2012-04-424135","article-title":"Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium","volume":"120","author":"Jacobsohn","year":"2012","journal-title":"Blood"},{"issue":"12","key":"2020071614175854700_B58","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bmt.2014.188","article-title":"NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD","volume":"49","author":"Curtis","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B59","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbmt.2013.01.013","article-title":"National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis","volume":"19","author":"Baird","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020071614175854700_B60","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3324\/haematol.2011.049841","article-title":"The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality","volume":"96","author":"Pidala","year":"2011","journal-title":"Haematologica"},{"issue":"10","key":"2020071614175854700_B61","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3324\/haematol.2014.109611","article-title":"Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease","volume":"99","author":"Inamoto","year":"2014","journal-title":"Haematologica"},{"issue":"10","key":"2020071614175854700_B62","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/bmt.2016.131","article-title":"Confounding factors affecting the National Institutes of Health (NIH) Chronic Graft-Versus-Host Disease Organ-Specific Score and global severity","volume":"51","author":"Aki","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"15","key":"2020071614175854700_B63","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1182\/blood-2011-03-344390","article-title":"Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria","volume":"118","author":"Arai","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2020071614175854700_B64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bmt.1705247","article-title":"Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation","volume":"37","author":"Atsuta","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2020071614175854700_B65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12185-013-1268-1","article-title":"Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease","volume":"97","author":"Aisa","year":"2013","journal-title":"Int J Hematol"},{"issue":"3","key":"2020071614175854700_B66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ophtha.2011.08.040","article-title":"Validation of measurement scales in ocular graft-versus-host disease","volume":"119","author":"Inamoto","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"2020071614175854700_B67","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201410-1818OC","article-title":"Budesonide\/formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation","volume":"191","author":"Bergeron","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2020071614175854700_B68","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","article-title":"Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation","volume":"22","author":"Williams","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B69","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.38293","article-title":"Assessment of joint and fascia manifestations in chronic graft-versus-host disease","volume":"66","author":"Inamoto","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2020071614175854700_B70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1078-0432.CCR-15-1443","article-title":"A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation","volume":"22","author":"Arai","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"25","key":"2020071614175854700_B71","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1182\/blood-2012-09-453928","article-title":"Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD","volume":"120","author":"de Masson","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2020071614175854700_B72","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood-2009-02-204156","article-title":"Imatinib for refractory chronic graft-versus-host disease with fibrotic features","volume":"114","author":"Olivieri","year":"2009","journal-title":"Blood"},{"issue":"25","key":"2020071614175854700_B73","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2013-05-494278","article-title":"Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD","volume":"122","author":"Olivieri","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2020071614175854700_B74","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbmt.2015.03.006","article-title":"Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease","volume":"21","author":"Baird","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2020071614175854700_B75","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archdermatol.2009.78","article-title":"Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease","volume":"145","author":"Clark","year":"2009","journal-title":"Arch Dermatol"},{"issue":"4","key":"2020071614175854700_B76","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1468-3083.2003.00516.x","article-title":"Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography","volume":"17","author":"Gottl\u00f6ber","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"2020071614175854700_B77","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.bbmt.2014.06.014","article-title":"Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"20","author":"Galb\u00e1n","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020071614175854700_B78","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/nm.2971","article-title":"Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression","volume":"18","author":"Galb\u00e1n","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"2020071614175854700_B79","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbmt.2009.09.010","article-title":"Oral chronic graft-versus-host disease scoring using the NIH consensus criteria","volume":"16","author":"Treister","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020071614175854700_B80","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbmt.2011.04.002","article-title":"A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change","volume":"17","author":"Mitchell","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2020071614175854700_B81","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2008-03-141481","article-title":"A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease","volume":"112","author":"Flowers","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2020071614175854700_B82","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071614175854700_B83","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bbmt.2015.12.026","article-title":"Content validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as assessed by cognitive interviews","volume":"22","author":"Merkel","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2020071614175854700_B84","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.bbmt.2016.03.013","article-title":"Translation, cross-cultural adaptation, and validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian population","volume":"22","author":"Vasconcellos de Souza","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020071614175854700_B85","article-title":"How to Score Version 2 of the SF-36 Health Survey","author":"Ware","year":"2000"},{"issue":"4","key":"2020071614175854700_B86","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2020071614175854700_B87","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbmt.2010.05.018","article-title":"Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Herzberg","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020071614175854700_B88","unstructured":"US Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Prodcut Development to Support Labeling Claims. December 2009. http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/UCM193282.pdf. Accessed November 9, 2015."},{"issue":"3","key":"2020071614175854700_B89","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1513\/AnnalsATS.201309-305OC","article-title":"Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease","volume":"11","author":"Leidy","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"2020071614175854700_B90","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2015-08-662874","article-title":"Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease","volume":"127","author":"Palmer","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2020071614175854700_B91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbmt.2010.06.018","article-title":"Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease","volume":"17","author":"Martin","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"2020071614175854700_B92","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2012-11-465583","article-title":"Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2020071614175854700_B93","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2014-03-563544","article-title":"Failure-free survival after initial systemic treatment of chronic graft-versus-host disease","volume":"124","author":"Inamoto","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2020071614175854700_B94","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"issue":"1","key":"2020071614175854700_B95","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/bmt.2013.129","article-title":"Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force","volume":"49","author":"Duarte","year":"2014","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/1\/30\/1398864\/blood686642.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/1\/30\/1398864\/blood686642.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T21:54:14Z","timestamp":1594936454000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/1\/30\/35839\/Classification-systems-for-chronic-graftversushost"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-07-686642","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]}}}